
Schematic illustration of the new MOF Antibody crystals and their ability to specifically seek out cancer cells to detect them and deliver highly potent drugs with unprecedented precision.
CREDIT: Dr Francesco Carraro and Prof Paolo Falcaro (Co-First and Co-Senior author on the Advanced Materials Paper)
It sounds like the stuff of science fiction: a man-made crystal that can be attached to antibodies and then supercharge them with potent drugs or imaging agents that can seek out diseased cells with the highest precision, resulting in fewer adverse effects for the patient.
However, that is precisely what researchers from the Australian Centre for Blood Diseases at Monash University in collaboration with the TU Graz (Austria) have developed: the world’s first metal-organic framework (MOFs) antibody-drug delivery system that has the potential to fast-track potent new therapies for cancer, cardiovascular and autoimmune diseases.
The in vitro study showed that when MOF antibody crystals bind to their target cancer cells and if exposed to the low pH in the cells, they break down, delivering the drugs directly and solely to the desired area.
The metal-organic framework, a mixture of metal (zinc) and carbonate ions, and a small organic molecule (an imidazole, a colourless solid compound that is soluble in water) not only keeps the payload attached to the antibody but can also acts as a reservoir of personalised therapeutics. This is a benefit with the potential to become a new medical tool to target specific diseases with customised drugs and optimised doses.
The findings are now published in the world-leading journal Advanced Materials.
Co-senior author Professor Christoph Hagemeyer, Head of the NanoBiotechnology Laboratory at the Australian Centre for Blood Diseases, Monash University, says while more funding is needed to take the research into the next phase and to patients, the new method is cheaper, faster and more versatile than anything available currently.
“The method offers the opportunity to personalise treatment and given the precision possible, may eventually change the current dosage needed for patients, resulting in fewer side effects and making treatments cheaper,” said Professor Hagemeyer.
Co-first author Dr Karen Alt, Head of the Nano Theranostics Laboratory at the Australian Centre for Blood Diseases, Monash University, says: “With just 0.01 per cent of chemotherapy currently reaching the cancer tissue, this revolutionary new method can boost the potency of the drugs reaching their target.”
“With over 80 different monoclonal antibodies approved for clinical use, this approach has enormous potential to improve these antibodies for the targeted delivery of diagnostic agents and therapeutic drugs. The goal is that ultimately the clinical translation of this technology will improve the quality of life for patients suffering from serious diseases,” said Dr Alt.
Original Article: Researchers develop a world-first antibody-drug delivery system
More from: Monash University | Graz University of Technology
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Antibody-drug delivery system
- Nanotechnology in Therapeutics
Although progress in the application of nanotechnology to drug delivery has been dramatic and successful, as evidenced by some nanodrugs now on the market, several main challenges remain in this ...
- Nanotechnology in Therapeutics
Various nanoforms have been attempted as drug delivery systems, varying from biological substances, such as albumin, gelatin and phospholipids for liposomes, to chemical substances, such as ...
- Leading innovators in antibody-drug conjugates for the pharmaceutical industry
Antibody-drug conjugates (ADCs) are a type of targeted cancer therapy that combine the specificity of monoclonal antibodies (mAbs) with the cytotoxic effects of chemotherapeutic drugs. In an ADC, a ...
- Leading innovators in drug delivery nanoparticles for the pharmaceutical industry
A nanoparticle is a small particle ranging in size from 1 to 100 nanometers. Nanoparticles are used as novel drug delivery systems to deliver drugs to specific tissues and to provide controlled ...
- Drug Kinetics – News and Features
Researchers have developed the world’s first metal-organic framework (MOFs) antibody-drug delivery system that has the potential to fast-track potent new therapies for cancer, cardiovascular and ...
Go deeper with Google Headlines on:
Antibody-drug delivery system
[google_news title=”” keyword=”antibody-drug delivery system” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Metal-organic framework antibody-drug delivery
- Porous Metal-Organic Framework (MOF) Materials: Design Strategy, Synthesis, Sensing and Catalysis
Porous Metal-Organic Frameworks (MOFs) materials are built by assembly of different metal ions/clusters (inorganic nodes) and bridging functional organic ligands (linkers) via coordination bonds. They ...
- Metal-organic frames (MOF) - Based Materials and Their Applications
MOF-based materials for a variety of applications, gas adsorption, gas separation and storage, participation in catalytic reactions, sensor applications, drug molecular delivery, etc. Keywords: ...
- Leading innovators in antibody-drug conjugates for the pharmaceutical industry
Antibody-drug conjugates (ADCs) are a type of targeted cancer therapy that combine the specificity of monoclonal antibodies (mAbs) with the cytotoxic effects of chemotherapeutic drugs. In an ADC, a ...
- DNA-Functionalized Porphyrinic Metal–Organic Framework-Based Drug Delivery System for Targeted Bimodal Cancer Therapy
Find more information on the Altmetric Attention Score and how the score is calculated. A DNA-functionalized porphyrinic MOF (porMOF) drug delivery system was successfully constructed. porMOF as a ...
- Polydopamine-Modified Zeolite Imidazole Framework Drug Delivery System for Photothermal Chemotherapy of Hepatocellular Carcinoma
Find more information on the Altmetric Attention Score and how the score is calculated. Metal–organic frameworks (MOFs) are promising drug-delivering platforms for their intrinsic capability of ...
Go deeper with Google Headlines on:
Metal-organic framework antibody-drug delivery
[google_news title=”” keyword=”metal-organic framework antibody-drug delivery” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]